Cargando…
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
The strategy of using existing drugs originally developed for one disease to treat other indications has found success across medical fields. Such drug repurposing promises faster access of drugs to patients while reducing costs in the long and difficult process of drug development. However, the num...
Autores principales: | Nowak-Sliwinska, Patrycja, Scapozza, Leonardo, Altaba, Ariel Ruiz i |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528778/ https://www.ncbi.nlm.nih.gov/pubmed/31034926 http://dx.doi.org/10.1016/j.bbcan.2019.04.005 |
Ejemplares similares
-
Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
por: Dalwadi, Shraddha M., et al.
Publicado: (2023) -
Comparative oncology approach to drug repurposing in osteosarcoma
por: Parrales, Alejandro, et al.
Publicado: (2018) -
Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
por: Zoetemelk, Marloes, et al.
Publicado: (2020) -
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
por: Rausch, Magdalena, et al.
Publicado: (2021) -
Oncology Drug Repurposing for Sepsis Treatment
por: Rumienczyk, Izabela, et al.
Publicado: (2022)